Kuopion yliopistollinen sairaala
Kuopio University Hospital

Julkaisut 2001
Publications 2001

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aalto-Setälä K et al. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
2 Aaltomaa S, Ala-Opas M. The effects of transurethral needle ablation on symptoms of chronic pelvic pain syndrome.
3 Aaltomaa S et al. Brakyhoidolla sisäistä säteilyä eturauhaseen.
4 Aaltomaa S et al. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
5 Aaltomaa SH et al. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
6 Ahonen K et al. Varhaiskokemukset Integral-varresta (BiometR) Femurin reartroplastioissa.
7 Airaksinen KEJ et al. Effects of noradrenaline on human vagal baroreflexes.
8 Airaksinen O. Tulehduskipulääkkeiden tulevaisuus.
9 Airaksinen O. Selkävaivan hoitoperiaatteet.
10 Airaksinen O. Hieronnan vaikutukset.
11 Airaksinen O, Kouri JP. Akupunktuuri kivunhoitomenetelmänä.
12 Airaksinen O et al. Monitoring of muscle fatigue during isokinetic exercise.
13 Airas U, Heinonen S. Napanuorasolmun kliininen merkitys obstetriikassa.
14 Ala-Haavisto R. Di-anoigostinen järjestelmä. Filosofis-teoreettinen diagnostinen käsitteistö hoitotyöhön ja hoitotieteeseen.
15 Alafuzoff I. Neuropatologinen tutkimus.
16 Alamowitch S et al. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis.
17 Alhava E, Viikari J. Luissa on muitakin sairauksia kuin osteoporoosi.
18 Anderson SD et al. Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices.
19 Antikainen R. Tytön salaisuus ja päiväperho.
20 Antikainen R et al. Mood improvement reduces memory complaints in depressed patients.
21 Appelberg BG et al. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
22 Arnala I et al. Bone histomorphometry in celiac disease.
23 Arokoski JP et al. Back and abdominal muscle function during stabilization exercises.
24 Arokoski JPA, Lammi MJ. Glukosamiinisulfaatti nivelrikon hoidossa.
25 Arokoski JPA et al. Nivelrikon etiopatogeneesi.
26 Arokoski JPA et al. Osteoporoosin lääkkeetön ehkäisy ja hoito. Oikea ravitsemus ja liikunta elämäntavaksi.
27 Arponen R, Airaksinen O. Hoitava hieronta.
28 Arponen R, Airaksinen O. Asiakaslähtöinen hierontatyö.
29 Arponen R, Airaksinen O. Fysikaaliset hoidot.
30 Arponen R et al. Hieronnan käyttömahdollisuudet ja soveltaminen.
31 Astuti D et al. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
32 Auranen M et al. MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features.
33 Badra LJ et al. Respiratory modulation of human autonomic rhythms.
34 Bailey CJ et al. Transcranial magnetic stimulation as a tool for cognitive studies.
35 Benavente O et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis.
36 Berg M. Rintasyövän diagnostiikka radiologian erikoislääkärin näkökulmasta.
37 Berg M et al. Suolistoiskemian hoito pallolaajennuksella ja stentillä.
38 Bergström KA et al. Dopamine transporter in vitro binding and in vivo imaging in the brain.
39 Björklund M et al. Spatial working memory improvement by an alpha2-adrenoceptor agonist dexmedetomidine is not mediated through alpha2C- adrenoceptor.
40 Blomgren K et al. A prospective study on pros and cons of electrodissection tonsillectomy.
41 Bras APM et al. Spermidine/spermine N1-acetyltransferase catalyzes amantadine acetylation.
42 Bräsen JH et al. Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries.
43 Butovas S et al. Differential effect of the alfa2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke.
44 Böhm J. Prognosis of Differentiated Thyroid Carcinoma. Relation to Clinical Factors and Cell Adhesion.
45 Callister LC et al. Giving birth: perceptions of Finnish childbearing women.
46 Campbell BCV et al. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia withLewy bodies and Parkinson`s disease.
47 Castrén E, Castrén M. Hermosolusiirrot neurologisten tautien hoidossa.
48 Castrén M et al. Subcellular localization of fragile X mental retardation protein with I304N mutation in the RNA-binding domain in cultured hippocampal neurons.
49 Chen Y et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism.
50 Clarke NA et al. Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients.
51 Cohn JN et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
52 Deprest J et al. Towards an endoscopic intra-uterine treatment for congenital diaphragmatic hernia: preclinical experimental studies.
53 Devlieger R et al. Amniodistentie met stikstofoxide versus vocht in een schapenmodel voor foetoscopische chirurgie: invloed op de operatieduur en foetaal zuur-base-evenwicht.
54 Dhingra VK et al. Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury.
55 Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study.
56 Dickstein K et al. Comparison of baseline data, initial course, and management: Losartan versus Captopril following acute myocardial infarction (The OPTIMAAL Trial).
57 DiSilvestro MR et al. Biphasic poroviscoelastic simulation of the unconfined compression of articular cartilage: I-simultaneous prediction of reaction force and lateral displacement.
58 Du AT et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer´s disease.
59 Dunder U, Mononen I. Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria.
60 Ebeling F et al. Factors predicting interferon treatment response in patients with chronic hepatitis C: late viral clearance does not preclude a sustained response.
61 Ebeling H et al. Somatically expressed psychological distress and alexithymia in adolescence - reflectig unbearable emotions?
62 Elo J et al. Rohdossa löytyy.
63 Eloniemi-Sulkava U et al. Effects of supporting community-living demented patients and their caregivers: A randomized trial.
64 Eloranta M-L et al. Risk of obstetric cholestasis in sisters of index patients.
65 Elovaara I et al. Immunoglobuliinin käyttö neurologisten tautien hoidossa.
66 Enckell H. "I want to know, too". Psychoterapy with a visually impaired boy.
67 Enckell H. Psychic reality and psychoanalysis: a look through the theory of methaphor.
68 Enholm B et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
69 Ensio A. Hoitotyön toiminnan mallintaminen.
70 Eray M et al. Flow cytometric analysis of apoptotic subpopulatios with a combination of Annexin V-FITC, propidium iodide, and SYTO 17.
71 Eriksson BI et al. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
72 Erkinjuntti T, Pirttilä T. Vaskulaariset dementiat.
73 Erkinjuntti T et al., toim. Muistihäiriöt ja dementia.
74 Erkinjuntti T et al. Muistihäiriöt ja dementia.
75 Erkkilä A. Diet, Serum Lipids and Serum Lipid Related Risk Factors in Patients with Coronary Heart Disease. A Cross-sectional Study.
76 Erkkilä AT et al. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose 1-3.
77 EUROASPIRE I and II Group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries.
78 EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II Euro Heart Survey Programme.
79 Everson SA et al. Stress-induced blood pressure reactivity and incident stroke in middle-aged men.
80 Felszeghy S et al. The distribution pattern of the hyaluronan receptor CD44 during human tooth development.
81 Finnilä S et al. Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNA.
82 Finnish Best Practice Guidelines (FBPG) työryhmä et al. Kroonista munuaisten vajaatoimintaa sairastavien potilaiden anemian hoito.
83 Forss H, Widström E. From amalgam to composite: selection of restorative materials and restoration longevity in Finland.
84 Golay X et al. Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle.
85 Goldstein S et al. Metoprolol controlled release/extended release in patients with severe heart failure: Analysis of the experience in the MERIT-HF Study.
86 Greaves DR et al. Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions.
87 Grieve R et al. A comparison of the costs and survival of hospital-admitted stroke patients across Europe.
88 Gröhn OHJ, Kauppinen RA. Assessment of brain tissue viability in acute ischemic stroke by BOLD NMR.
89 Grönlund-Pakkanen S et al. Effect of photodynamic therapy on urinary bladder function: an experimental study with rats.
90 Gul HI et al. Antifungal activity of some mono, bis and quaternary Mannich bases derived from acetophenone.
91 Gylling H, Miettinen TA. A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease.
92 Haapala J et al. Decline after immobilisation and recovery after remobilisation of synovial fluid il1, timp, and chondroitin sulphate levels in young beagle dogs.
93 Haapasalo A et al. Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival.
94 Hakkola J et al. Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers.
95 Halimaa S-L. Video recording as a method of data collection in nursing research.
96 Halimaa S-L. Hoidetaanko keskoslapsen kipua? . Tutkimus hoitajien valmiuksista arvioida ja hoitaa keskoslapsen kipua.
97 Halimaa S-L et al. Pain relieving measures for prosedural pain in premature babies: an observational study.
98 Halimaa SL et al. Knowledge, assessment and management of pain related to nursing procedures used with premature babies: questionnaire study for caregivers.
99 Halinen MO. Ikä ja antikoagulanttihoito.
100 Hallikainen M. Role of Plant Stanol Ester- and Sterol Ester-Enriched Margarines in the Treatment of Hypercholesterolemia.
101 Halonen T et al. Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.
102 Halonen T et al. Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.
103 Harvima I. Kroonisten säärihaavojen hoito edellyttää yhteistyötä ja tehokkaita menetelmiä.
104 Heikkilä A et al. Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes.
105 Heikkilä A et al. Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies.
106 Heikkinen JO et al. Quality of dynamic radionuclide renal imaging: multicentre evaluation using a functional renal phantom.
107 Heikkinen M et al. Prevalence of gastric metaplasia in the duodenal buld is low in Helicobacter pylori postive non-ulcer dysplasia patients.
108 Heikkinen P et al. Effects of mobile phone radiation on X-ray-induced tumorigenesis in mice.
109 Heikkinen P et al. Effects of 50 Hz magnetic fields on cancer induced by ionizing radiation in mice.
110 Heikkinen T, Isola A. Painehaavaumapotilaat Itä-Suomen läänin hoitolaksien vuodeosastoilla keväällä 1999.
111 Heinonen S et al. Maternal susceptibility locus for obstetric cholestasis maps to chromosone region 2p13 in finnish patients.
112 Heinonen S et al. Apolipoprotein E alleles in women with polycystic ovary syndrome.
113 Heinonen S, Saarikoski S. Reproductive risk factors of fetal asphyxia at delivery: A population based analysis.
114 Heinonen S et al. Weights of placentae from small-for-gestational age infants revisited.
115 Heiskanen JT et al. Bone mineral metabolism after total gastrectomy.
116 Heiskanen JT et al. Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia.
117 Helenius M et al. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappaB binding activity.
118 Helin-Tanninen M et al. Karmelloosigeelin.
119 Helin-Tanninen M et al. Uudet teknologiat farmasiassa ja potilaiden hoidossa: ESCP:n kongressi, Basel, 11.-14.10.2000.
120 Helin-Tanninen M et al. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension.
121 Helin-Tanninen M et al. Enteral suspension of nifedipine for neonates. Part 1. Formulation of nifedipine suspension for hospital use.
122 Heliö T et al. Laajentavan kardiomyopatian geenivirheet.
123 Helkala E-L et al. Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample.
124 Helminen HJ et al. Polven ja lonkan nivelrikon ehkäisy - haavettako vain?
125 Heydeck D et al. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions.
126 Hietanen A et al. Kehitystyötä KYS:ssa: Urakehitysohjelma helpottaa osaamisen arviointia.
127 Hietanen M, Hänninen T. Laaja neuropsykologinen tutkimus.
128 Hiippala A et al. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study.
129 Hiltunen M et al. Genome-wide linkage disequilibrium mapping of late-onset Alzheimr´s disease in Finland.
130 Hiltunen M, Soininen H. Genes, proteins and brain disease.
131 Hiltunen MO et al. Gene therapy methods in cardiovascular diseases.
132 Hiltunen TP et al. Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor.
133 Hintikka J et al. Are alexithymia and depression distinct or overlapping constructs? A study in a general population.
134 Hintikka J et al. Suicidal ideation in the Finnish general population. A 12-month follow-up study.
135 Hippeläinen M. Endometrioosi.
136 Hippeläinen M et al. Synnytykseen liittyvän vaikean verenvuodon embolisaatiohoito.
137 Hirvonen A et al. Polymorphic GSTs and cancer predisposition.
138 Hokkanen L et al. Kognitiiviset häiriöt ja niiden tutkiminen.
139 Hongisto T. HB-näytteenotto ja määritys.
140 Honkalampi K. Studies on the Relationship Between Alexithymia and Depression.
141 honkalampi k. Aleksitymia ja masentuneisuus.
142 Honkalampi K et al. Alexithymia in patients with major depressive disorder and comorbid cluster C personality disorders: a 6-month follow-up study.
143 Honkalampi K et al. Alexithymia and depression. A prospective study of patients with major depressive disorder.
144 Honkalampi K et al. Why do alexithymic features appear to be stable? A 12-month follow-up study of a general population.
145 Honkalampi K et al. Does the cellular phone help to communicate when face-to-face contacts are difficult?
146 Honkanen R et al. Effect of calcium on bone loss and fractures according to estrogen repletion status.
147 Hujakka H et al. New immunochromatographic rapid test for diagnosis of acute Puumala virus infection.
148 Hurskainen R et al. Psychosocial and other characteristics of women complaining of menorrhagia, with and without actual increased menstrual blood loss.
149 Hurskainen R et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy fot treatment of menorrhagia: a randomised trial.
150 Huttunen K et al. Comparison of mycobacteria-induced cytotoxicity and inflammatory responses in human and mouse cell lines.
151 Huttunen M et al. Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators.
152 Huusko TM et al. Lonkkamurtumapotilaiden kuntoutus Keski-Suomessa.
153 Huusko TM et al. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland.
154 Huuskonen J. Osteoporosis in Men.
155 Huuskonen J et al. Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats.
156 Huuskonen J et al. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
157 Huuskonen J et al. Regular physical exercise and bone mineral density: a four-year controlled randomized trial in middle-aged men. The DNASCO study.
158 Hyttinen MM et al. Age matters: collagen birefringeance of superficial articular cartilage is increased in young guinea-pigs but descreased in older animals after idential physiological type of joint loading.
159 Hyttinen MM et al. Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer.
160 Häkkinen A et al. Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: comparison with healthy women.
161 Häkkinen A et al. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis.
162 Häkkinen K et al. Changes in electromyographic activity, muscle fibre and force production characteristics during heavy resistance/power strength training in middle-aged and older men and women.
163 Häkkinen K et al. Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women.
164 Hänninen T, Pirttilä T. Varhaiset neuropsykologiset muutokset dementiassa. Kokemuksia Cerad-tehtäväsarjan käytöstä.
165 Hänninen T, Pulliainen V. Neuropsykologinen seulonta.
166 Hänninen-Nousiainen P et al. Suomalaisen kätilötyön historia - tuntemalla menneisyytemme osaamme rakentaa tulevaisuutta.
167 Ihalainen JA et al. alpha2c-Adrenoceptors modulate the effect of methylphenidate on response rateand discrimination accuracy in an operant test.
168 Ikonen M. Apoptosis-associated Changes in Neuronal Gene Expression. With Special Emphasis on the Insulin-like Growth Factor System.
169 Ikonen S, Tanila H. Effects of metrifonate on the hippocampal theta rhythm of freely moving intact and MS-lesioned mice.
170 Ikäheimo K et al. Adverse ocular effects of flecainide.
171 Ikäheimo R. Aikuisten virtsatieinfektioiden diagnostiikka ja hoito.
172 Ikäheimo R. Virtsatieinfektioiden uudet hoitosuositukset.
173 Immonen J et al. Skin-prick test findings in students from moisture- and mould-damaged schools: A 3-year follow-up study.
174 Jakob SM. Splanchnic Vasoregulation and Metabolism. New Insights into Physiology.
175 Jakob SM et al. Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion.
176 Jakob SM et al. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs.
177 Jakovljevic D et al. Socioeconomic status and ischemic stroke: the FINMONICA stroke register.
178 Jakovljevic D et al. Socioeconomic differences in the incidence, mortality and prognosis of intracerebral hemorrhage in Finnish adult population.
179 Jakovljevic D et al. Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA stroke register.
180 Jansen MCJF et al. Cohort analysis of fruit and vegetable consumption and lung cancer mortality in european men.
181 Jantunen E. Kantasolusiirtopotilaiden aspergillusinfektiot.
182 Jantunen E. Pitkäkestoinen trombosytopenia.
183 Jantunen E et al. Autologiset kantasolusiirrot myeloomapotilaiden hoidossa.
184 Jantunen E et al. Keliakia ja lymfooma.
185 Jantunen E et al. Autologiset kantasolusiirrot non-Hodgkin-lymfoomissa.
186 Jauhiainen K et al. Kliininen kuormituskoe sepelvaltimotaudin diagnostiikassa.
187 Jensen KM-E et al. Reconstructive urology in the Nordic countries.
188 Johansson R. Syövän vai hoidon aiheuttamat oireet.
189 Jokinen C et al. Microbial etiology of community-acquired pneunomia in the adult population of 4 municipalities in Eastern Finland.
190 Jokinen JJ et al. Pitkäaikaisennuste ja elämänlaatu sepelvaltimoiden ohitusleikkauksen jälkeen.
191 Jokiniemi T, Ikäheimo R. Etyleeniglykolimyrkytykset Pohjois-Savossa 1984-98.
192 Jolkkonen E et al. Projections from the amygdalo-piriform transition area to the amygdaloid coplex: A PHA-L study in rat.
193 Jolkkonen E et al. Interconnectivity between the amygdaloid complex and the amygdalostriatal transition area: a PHA-L study in rat.
194 Jolkkonen J et al., ed. 11th Nordic Meeting on Cerebrovascular Diseases and 2nd Biennial Symposium on Ischaemic Stroke.
195 Jormanainen V et al. Lääkäreiden tupakoiville potilailleen suosittelemat tupakoinnin lopettamismenetelmät vuonna 1995.
196 Juntunen A et al. A major role of viruses in convulsive status epilepticus in children: a prospective study of 22 children.
197 Jussila J et al. Inflammatory responses in mice after intratracheal instillation of spores of streptomyces californicus isolated from indoor air of a molby building.
198 Jutila L et al. Neurobiology of epileptogenesis in the temporal lobe.
199 Jutila L et al. MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy.
200 Juva K et al. Sex differences in cognitive performance among the very old - Mini-mental state examination in a population aged 85 years and over.
201 Jämsén T et al. Results of infrainguinal bypass surgery: An analysis of 263 consecutive operations.
202 Järvinen R, Uusitupa M. D-vitamiini ja eturauhassyöpä.
203 Jääskeläinen J et al. Sexual function and fertility in adult females and males with congenital adrenal hyperplasia.
204 Kaipiainen-Seppänen O et al. Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.
205 Kaipiainen-Seppänen O, Hyvärinen L. To the editor (Adverse reactions to rifabutin).
206 Kaipiainen-Seppänen O, Savolainen A. Changes in the incidence of juvenile rheumatoid arthritis in Finland.
207 Kallinen J et al. Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland.
208 Kallinen J et al. Antenatal genetic screening for congenital nephrosis.
209 Kallinen J et al. Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: integration of gene tests and fetal karyotyping.
210 Kallio J et al. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans.
211 Kaminska R. The Role of Mast Cell Proteinases in the Formation of Skin Blisters.
212 Kanerva J et al. Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
213 Kanerva J et al. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
214 Kanerva L et al. A multicenter study of patch test reactions with dental screening series.
215 Kannisto S. Adrenocortical Function, Bone Metabolism, and Growth in Asthmatic Children During the Initiation Phase of Inhaled Steroid Therapy.
216 Kannisto S et al. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids.
217 Kanto-Ronkanen A. Pieniä poimintoja asuntomessuilta Kajaanista.
218 Kanto-Ronkanen A. Turvallisuutta kotona asumiseen.
219 Kanto-Ronkanen A. Ympäristönhallintajärjestelmiä käytetään monipuolisesti.
220 Kareinen A et al. Cardiovascular risk factors associated with insulin resistence cluster in families with early-onset coronary heart disease.
221 Karjalainen JM. Transcription factors and other dysregulated proteins in melanoma prognosis.
222 Karkkainen MJ et al. A model for gene therapy of human hereditary lymphedema.
223 Karonen J. TT edelleen yleisin aivoiskemian kuvantamisessa.
224 Karonen J. Diffusion and Perfusion Magnetic Resonance Imaging in Human Acute Ischemic Stroke.
225 Karonen JO et al. Evolution of MR contrast enhancement patterns during the first week after acute ischemic stroke.
226 Karonen JO et al. Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT.
227 Karpanen T et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
228 Karvonen MK et al. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
229 Kaste M et al. Aivoverenkiertohäiriöt.
230 Kataja V et al. Kudoksensisäinen sädehoito paikallisen eturauhassyövän hoidossa.
231 Kaukanen E. Keuhkoembolian hajottaminen katetrilla antaa sydämen toiminnalle lisäaikaa.
232 Kaukua J et al. Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking.
233 Kauppinen J et al. PCR-based typing of Mycobacterium avium isolates in an epidemic among farmed lesser white-fronted geese (Anser erythropus).
234 Kauppinen R et al. Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma.
235 Kauppinen T et al. Kiintymyssuhde vanhempiin ja psykosomaattinen oireilu nuoruusiässä.
236 Kauppinen T et al. Quantitation of neuroreceptors: a need for better SPECT imaging.
237 Kavec M et al. Use of spin echo T2 BOLD in assessment of cerebral misery perfusion at 1.5 T.
238 Kerokoski P et al. Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality.
239 Kerokoski P et al. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
240 Keskimäki M et al. EPEC, EAEC and STEC in stool specimens: Prevalence and molecular epidemiology of isolates.
241 Kettunen J et al. The fixation properties of carbon fiber-reinforced liquid crystalline polymer implant in bone: An experimental study in rabbits.
242 Kettunen MI et al. Cerebral T1rho relaxation time increases immediately upon global ischemia in the rat independently of blood glucose and anoxic depolarization.
243 Kimbell-Dunn MR et al. Work-related respiratory symptoms in New Zealand farmers.
244 Kivinen PK et al. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
245 Kivipelto M et al. Midlife vascular risk factors and late-life mild cognitive impairment. A population-based study.
246 Kivipelto M et al. Midlife vascular risk factors and Alzheimer´s disease in later life: longitudinal, population based study.
247 Knuuti J et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
248 Koistinaho M et al. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques.
249 Koistinen HA et al. Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid.
250 Koivisto T et al. Gastric tonometry after subarachnoid hemorrhage.
251 Koivisto T, Vapalahti M. Comment to (Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: A clinical, prospective, randomized, controlled study).
252 Koivula I. Uudet antimikrobit antimikrobiresistenssiä vastaan.
253 Koivula IH. Epidemiology of community-acquired pneumonia.
254 Koivumaa-Honkanen H et al. Self-reported life satisfaction and recovery from depression in a 1-year prospective study.
255 Koivumaa-Honkanen H et al. Life satisfaction and suicide: a 20-year follow-up study.
256 Koivunen RM et al. Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.
257 Kokki A et al. Kun päiväkirurgia lisääntyy, kivunhoito jää kodin vastuulle.
258 Kokki H. Lastenanestesiologia 2001.
259 Kokki H, Reinikainen M. Levopuudutteet lasten puudutuksissa.
260 Kokki H et al. Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children.
261 Kokki H et al. Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children.
262 Kolehmainen M et al. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
263 Konttinen YT et al. Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses.
264 Korhonen K et al. Reasons for and costs of hospitalization for pediatric asthma: A prospective 1-year follow-up in a population-based setting.
265 Korhonen S et al. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: A controlled, population-based study.
266 Korhonen V et al. Effect of major depression on the self-image of adolescent boys and girls.
267 Korhonen V-P et al. Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to antiproliferative drugs.
268 Korkeila J et al. Psykiatrian alan lääkärien työuupumus.
269 Korppi M, Heiskanen-Kosma T. Bacterial community-acquired pneumonia in children: changes in causative agents.
270 Korppi M, Remes S. Serum procalcitonin in pneumococcal pneumonia in children.
271 Koskela H. Veripaikka ilmarinnan hoidossa.
272 Koskinen O et al. Increased risk of violent recidivism among adult males is related to single-parent family during childhood: the Northern Finland 1966 Birth Cohort Study.
273 Koskinen T. Laitosvanhusten mielenterveyshäiriöiden tunnistaminen ja hoito.
274 Koskinen T. Voidaanko lääkehoidon komplianssia parantaa?
275 Koskinen T. Näiline Dementsus. (pseudodementsus).
276 Koskiniemi M et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland.
277 Koukkunen H et al. C-reactive proteins, fibrinogen, interleukin-6 and tumour necrosis factor-alfa in the prognostic classification of unstable angina pectoris.
278 Koukkunen H et al. Ruling out myocardial infarction with Troponin T and creatine kinase MB massa: diagnostic and prognostic aspects.
279 Koukkunen H et al. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria.
280 Kouri JP, Airaksinen O. Kivun käsitteet selviksi.
281 Kraszpulski M et al. The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer´s disease.
282 Kromhout D et al. Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study.
283 Kröger H. Osteoporoottisten murtumien sekundaaripreventio ortopedin kannalta.
284 Krüüner A et al. Tuberculosis as an occupational hazard for health care workers in Estonia.
285 Kubová H et al. Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats.
286 Kuhmonen J et al. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
287 Kuikka JT. Modeling tissues contrast agent concentration: A solution to the tissue homogeneity model using a simulated arterial input function.
288 Kuikka JT et al. Imaging of the endothelial dysfunction in coronary atherosclerosis.
289 Kuikka JT et al. Effects of ageing on serotonin transporters in healthy females.
290 Kuikka JT et al. Reduced serotonin transporter binding in binge eating women.
291 Kumpulainen K et al. Psychiatric disorders and the use of mental health services among children involved in bullying.
292 Kumpulainen K, Säiniö M. Lasten psyykkiset häiriöt, oppiminen ja koulunkäynti.
293 Kurkinen K et al. Isoform-specific membrane translocation of protein kinase C after ischemic preconditioning.
294 Kurkinen K et al. Preconditioning with spreading depression activates specifically protein kinase Cdelta.
295 Kurl S et al. Systolic blood pressure response to exercise stress test and risk of stroke.
296 Kuusisto E et al. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies.
297 Kuusisto E et al. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells.
298 Kuusisto J et al. Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
299 Kvist T et al. Ihmisläheinen hoito-potilaskyselyn tulokset Kuopion yliopistollisessa sairaalassa, Iisalmen ja Varkauden aluesairaaloissa vuonna 2000.
300 Kylmä J et al. Hope, despair and hopelessness in living with HIV/AIDS: a grounded theory study.
301 Kylmä J et al. Dynamically fluctuating hope, despair and hopelessness along the HIV/AIDS continuum as described by caregivers in voluntary organizations in Finland.
302 Kylmä J et al. Voluntary caregivers' observations on the dynamics of hope across the continuum of HIV/AIDS: A focus group study.
303 Kylmä J et al. Dynamics of hope in living with HIV: professional caregivers' observations.
304 Kyrölä K et al. Preoperatiivinen MRI-artrografia rotator cuff-kirurgiassa.
305 Kähkönen S et al. Ethanol modulates cortical activity: direct evidence with combined TMS and EEG.
306 Kälviäinen R. Epilepsia ja ikääntyminen. Pääkirjoitus.
307 Kälviäinen R. Monotherapy trial design: conversion versus de novo.
308 Kälviäinen R. Long-term safety of tiagabine.
309 Kälviäinen R. Ikääntyneiden epilepsia yleistyy.
310 Kälviäinen R. Epilepsialääkkeet säilytettävä edelleen erityiskorvattavina.
311 Kälviäinen R. Terveiset Buenos Airesista.
312 Kälviäinen R. Kiitos luottamuksestanne.
313 Kälviäinen R, Keränen T. Epilepsia.
314 Kälviäinen R, Nousiainen I. Visual field defects with vigabatrin. Epidemiology and therapeutic implications .
315 Kälviäinen R, Äikiä M. Kognitiiviset häiriöt neurologisissa sairauksissa. Epilepsia.
316 Laakko K, Vänskä K. Kun yhteistyö toimii, laihdutusleikkaus sujuu.
317 Laakso M. Linkkejä muistihäiriö- ja dementiasivuille.
318 Laakso M. Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention.
319 Laakso M. Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
320 Laakso M. Diabetes and cardiovascular disease.
321 Laakso M. Diabetic macroangiopathy.
322 Laakso MP et al. A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia.
323 Laakso MP et al. Psychopathy and the posterior hippocampus.
324 Laasonen-Balk T et al. Cluster C personality disorder has no independent effect on stratial dopamine transporter densities in major depression.
325 Lahtinen P et al. Kivunhoito sydänleikkauksen jälkeen.
326 Laine TPJ et al. The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics.
327 Laine TPJ et al. Dopamine transporter density and novelty seeking among alcoholics.
328 Laitinen JT et al. [35S]GTPgammaS autoradiography reveals a wide distribution of Gi/o-linked ADP receptors in the nervous system: close similarities with theplatelet P2Y ADP receptor.
329 Laitinen KSM et al. Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.
330 Laivoranta-Nyman S et al. Differences between female and male patients with familial rheumatoid arthritis.
331 Lakka TA et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men.
332 Lakka TA et al. Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men.
333 Lamberg M. Infektio suussa - yleisterveys vaarassa.
334 Lamusuo S et al. [18F] FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.
335 Lanrson A et al. Stora skillnader i användingen av laboratorieanalyser mellan några utvalda laboratorier i Norden.
336 Laukkanen E et al. The stability and correlates of a negative coping self among adolescents.
337 Laukkanen E et al. A pessimistic attitude towards the future and low psychosocial functioning predict psychiatric diagnosis among treatment-seeking adolescents.
338 Laukkanen E et al. The effect of congenital handicap on personality development in adolescence.
339 Laukkanen E et al. Koulun yhteisöllisyys - väline vaikuttaa nuorten terveeseen kasvuun.
340 Laukkanen ER et al. Heavy drinking is associated with more severe psychosocial dysfunction among girls than boys in Finland.
341 Laukkanen JA et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men.
342 Laukkanen JA et al. Cardiovascular fitness as a predictor of mortality in men.
343 Laukkanen MO et al. EC-SOD gene therapy reduces paracetamol-induced liver damage in mice.
344 Laukkanen MO et al. Gene transfer of extracellular superoxide dismutase to atherosclerotic mice.
345 Laurikkala J et al. Analysis of the imputed female urinary incontinence data for the evaluation of expert system parameters.
346 Lauritsalo L, Mustonen P. Rintarekonstruktio proteesilla kohentaa itsetuntoa ja elämänkalaatua.
347 Lehtonen J. Psykoanalyysin tulevaisuudesta.
348 Lehtonen J. Psykoanalyysi 2000-luvulle.
349 Lehtonen J. Luottamus terveydenhuollossa.
350 Lehtovirta M. Perinnöllisyys ja geenitestit.
351 Leino K et al. Validation of a new respiratory inductive plethysmograph.
352 Leinonen V et al. Disc herniation-related back pain impairs feed-forward control of paraspinal muscles.
353 Leppänen PM et al. Optimized in situ PCR method for the detection of gene transfer vector in histological sections.
354 Leuppi JD et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
355 Leuppi JD et al. Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.
356 Liippo J et al. Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos gene.
357 Lindgren A et al. Cancer incidence in hypertensive patients in North Karelia, Finland.
358 Lindgren BF et al. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial.
359 Lindi V et al. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on lon-term weight change in Finnish non-diabetic subjects.
360 Lindén A-M et al. Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.
361 Lindén A-M et al. Uncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex.
362 Lintula H et al. Single-blind randomized clinical trial of laparoscopic versus open appendicectomy in children.
363 Lipponen P et al. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
364 Liu J et al. Gonadotrophins inhibit and activin induces expression of inhibin /activin beta-B subunit mRNA in cultured human granulosa-luteal cells.
365 Loimas S et al. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
366 Lozeva V et al. Changes in brain histamine H1 receptors in chronic hepatic encephalopathy.
367 Lozeva V et al. Increased density of brain histamine H1 receptors in rats with portacaval anastomosis and in cirrhotic patients with chronic hepatic encephalopathy.
368 Luiro K et al. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
369 Lumiaho A et al. Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.
370 Lundell L et al. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
371 Lundin J et al. Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study.
372 Lunt M et al. A statistical method to minimize magnification errors in serial vertebral radiographs.
373 Luostarinen A, Klemola L. Kokemuksia photodynaamisesta terapiasta.
374 Luostarinen A, Klemola L. Fotodynaaminen hoito.
375 Luostarinen L et al. Association between coeliac disease, epilepsy and brain atrophy.
376 Luostarinen LK et al. Coeliac disease in patients with cerebellar ataxia of unknown origin.
377 Lyyra-Laitinen T et al. Development of arthroscopic indentation technique for the diagnosis of cartilage degeneration.
378 Lyytikäinen H. Potilaan, omaisten ja henkilökunnan yhteistyö tehohoidon rajaamisessa.
379 Lyytikäinen H et al. Tehohoidon rajaaminen - käsiteanalyysi Walker & Avantin menetelmällä.
380 Länsimies E. Clinical Physiology 1998-2001.
381 Lång M et al. Outcome and resource utilization in gastroenterological surgery.
382 Makkonen N. Recovery, Recurrence and Familial Aspects in Preeclampsia-Counselling Patients and Their Families.
383 Makkonen N et al. Apolipoprotein E alleles in women with pre-eclampsia.
384 Manninen H. Toimenpideradiologia.
385 Manninen HI. Intravascular ultrasound imaging in the quantitation of atherosclerosis in vivo.
386 Manninen HI, Kaukanen ET. Drs Manninen and Kaukanen respond (to Branchial arterial access).
387 Manninen HI et al. Brachial arterial access: Endovascular treatment of failing Brescia-Cimino hemodialysis fistulas-initial success and long-term results.
388 Manninen P et al. Physical exercise and risk of severe knee osteoarthritis requiring arthroplasty.
389 Markkanen A et al. Effects of 50 Hz magnetic field on cell cycle kinetics and the colony forming ability of budding yeast exposed to ultraviolet radiation.
390 Marvanová M et al. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain.
391 Mattila MAK. Moderni lääketiede. Ruoka - liikunta - hyvinvointi.
392 Mattila MAK. Ydinlämpötilan lasku traumapotilailla.
393 Mattila MAK. 12. Maailman katastrofilääketieteen kongressi Lyonissa Ranskassa 2001.
394 Mehta PD et al. Amyloid beeta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.
395 Mehto P. Kuopion yliopistollisen sairaalan toimintolaskentapilottiprojektin loppuraportti.
396 Mehto P et al. Kammoksuttu kuolema.
397 Menotti A et al. The association of silent electrocardiographic findings with coronary deaths among elderly men in three European countries. The FINE study.
398 Menotti A et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations.
399 Mervaala E et al. SPECT and neuropsychological performance in severe depression treated with ECT.
400 Meurling CJ et al. Diurnal variations of the dominant cycle length of chronic atrial fibrillation.
401 Meurman JH, Koivula I. Vaaralliset infektiotaudit ja antibioottiresistenssi suun terveydenhuollon kannalta.
402 Miettinen H. Lonkan ja polven tekonivelleikkaus 2000-luvulla.
403 Miettinen H, Kettunen J. Lonkan ja polven tekonivelleikkaus vuosituhannen vaihteessa.
404 Miettinen HE et al. Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.
405 Miettinen VM et al. Release of fluoride from glass fiber-reinforced composite with multiphase polymer matrix.
406 Mikkonen M et al. Hippocampal plasticity in Alzheimer´s disease.
407 Mitrunen K et al. Polymorphic catechol-O-methyltransferase gene and breast cancer risik.
408 Mitrunen K et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
409 Mitrunen K et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.
410 Moilanen JS et al. Complex segregation analysis of Parkinson´s disease in the finnish population.
411 Molin D et al. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
412 Mrózek K et al. Clinical importance of cytogenetics in acute myeloid leukaemia.
413 Mussalo H et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension.
414 Mustonen P, Vanninen E. Vartijaimusolmukkeet rintasyövässä.
415 Mykkänen M, Virranta S. Vertaisarviointimenetelmä sairaanhoitajien toiminnan kehittämisessä tehohoidon osastolla-havainnointitutkimus.
416 Myllykangas L et al. Association of lipoprotein lipase Ser447Ter polymorhphism with brain infarction: a population-based neuropathological study.
417 Myllykangas-Luosujärvi R et al. Reply (to Amyloidosis in a series of 964 Portuguese rheumatoid arthritis patients).
418 Myllykangas-Luosujärvi R et al. Two clusters of different rheumatic diseases in moisture damaged buildings.
419 Myrvold HE et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
420 Mäkelä EA. Luutuumorit.
421 Mäkelä HI et al. Proton exchange as a relaxation mechanism for T1 in the rotating frame in native and immobilized protein solutions.
422 Mäkinen J et al. Morbidity of 10 110 hysterectomies by type of approach.
423 Mäkinen T et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
424 Mäntyjärvi M. Normal test scores in the Farnsworth-Munsell 100 hue test.
425 Mäntyjärvi M, Laitinen T. Normal values for the Pelli-Robson contrast sensitivity test.
426 Mäntyjärvi M et al. Clinical features and follow-up study in a family with X-linked progressive cone-rod dystrophy.
427 Mäntyjärvi M et al. Screening color vision in preschool-aged children.
428 Mäntyselkä P et al. Pain as a reason to visit the doctor: a study in Finnish primary health care.
429 Naaranlahti T, Saano S. Rabdomyolyysi lääkeaineinteraktion seurauksena.
430 Naaranlahti T, Saano S. Lääkkeen aiheuttama haimatulehdus.
431 Neva MH et al. Mortality associated with cervical spine disorders: a population-based study of 1666 patients with rheumatoid arthritis who died in Finland in 1989.
432 Niemelä M, Peuhkurinen K. Tieteelliseen näyttöön perustuva sydämen vajaatoiminnan lääkehoito.
433 Niemeläinen M et al. Kuopion yliopistollisen sairaalan luupankki.
434 Niemimaa M et al. Äitien veriseulonta keskiraskauden aikana paljastaa myös sikiön 18-trisomian.
435 Niemimaa M et al. First-trimester screening for Down`s syndrome in vitro fertilization pregnancies.
436 Niemimaa M et al. Evaluation of first trimester maternal serum and ultrasound screening for Down*s syndrome in Eastern and Northern Finland.
437 Nieminen MT et al. T2 Relaxation reveals spatial collagen architecture in articular cartilage: a comparative quantitative MRI and polarized light microscopic study.
438 Niskanen L et al. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen.
439 Niskanen M et al. Laadunvalvontaa anestesiaosastolla: kahden menetelmän vertailu komplikaatioiden kirjaamisessa.
440 Niskanen MM, Takala JA. Use of resources and postoperative outcome.
441 Nissinen J et al. Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?
442 Nissinen M et al. Smith-Lemli-Opitzin oireyhtymän diaknostiikka kaasukromatografian avulla.
443 Nitschke L et al. Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage.
444 Nobuhara K et al. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP.
445 Nousiainen I et al. No reversion in vigabatrin-associated visual field defects.
446 Nousiainen T. Karvasoluleukemian diagnostiikka ja nykyhoito.
447 Nousiainen T et al. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy.
448 Nousiainen T et al. Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.
449 Nousiainen T et al. Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
450 Nuikka M-L et al. The nurse's workload in care situations.
451 Närvänen O et al. Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL.
452 Närvänen O et al. Technical and clinical aspects about autoantibody assays for oxidized low density lipoprotein.
453 Ojala M et al. Epilepsia ja ajokyvyn arviointi - suomalainen menettelyohje.
454 Ojala M, Kälviäinen R. Insurability of patients with epilepsy: perspectives of physicians and insurance companies.
455 Ollikainen J et al. Chronic lung disease of the newborn is not associated with Ureaplasma urealyticum.
456 Paassilta P et al. Identification of a novel common genetic risk factor for lumbar disk disease.
457 Paavola P et al. Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21.
458 Paloneva J et al. CNS manifestations of Nasu-Hakola disease. A frontal dementia with bone cysts.
459 Papp A et al. Palovammat KYS:n palovammakeskuksessa 1994-2000.
460 Papp A et al. Local unilateral gastrocnemius flap in complicated total knee arthrosplasty.
461 Parkkinen L et al. alpha-Synuclein pathology is highly dependent on the case selection.
462 Partanen K et al. Aivojen kuvantaminen.
463 Pasonen-Seppänen S et al. Formation of permeability barrier in epidermal organotypic culture for studies on drug transport.
464 Pasonen-Seppänen S et al. Vitamin C enhances differentation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier.
465 Pelkonen M et al. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.
466 Penttilä HJ et al. Myocardial preservation during coronary surgery with and without cardiopulmonary bypass.
467 Penttilä I et al. Analyyttiset näkökohdat uuden sydäninfarktin kansainvälisen diagnostiikkasuosituksen mukaisesti toimittaessa.
468 Pesonen TM et al. Male suicide mortality in eastern Finland - urban-rural changes during a 10-year period between 1988 and1997.
469 Pienimäki J-P et al. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan.
470 Pietilä A-M, Vehviläinen-Julkunen K. Preventiivisen hoitotieteen tutkimuksen ja koulutuksen lähtökohtia.
471 Pietilä A-M, Vehviläinen-Julkunen K. Preventiivistä perhehoitotyötä kuvaavien tutkimusten tarkoitus ja tutkimustehtävät.
472 Pietilä A-M, Vehviläinen-Julkunen K. Tutkimusten aineistot ja menetelmät.
473 Pietilä A-M et al. Preventiivisen perhehoitotyön kehittäminen.
474 Pietilä A-M et al., toim. Preventiivinen perhehoitotyö. Terveyttä edistävien työmenetelmien arviointia Lapsiperhe-projektissa.
475 Pietilä A-M et al. Perhehoitotyö Lapsiperhe-projektissa: haastattelututkimus lapsiperheiden saamasta varhaisesta tuesta.
476 Pietilä M et al. Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase.
477 Pietinen P et al. Serum enterolactone and risk of breast cancer: A case-control study in Eastern Finland.
478 Pihlajamäki J et al. A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia.
479 Pihlajamäki J et al. The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
480 Pihlajamäki M et al. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
481 Pikkarainen M, Pitkanen A. Projections from the lateral, basal and accessory basal nuclei of the amygdala to the perirhinal and postrhinal cortices in rat.
482 Pirinen E et al. Mahapantaleikkaus lihavuuden kirurgisena hoitona.
483 Pirinen R et al. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarsinoma.
484 Pirinen RT et al. Reduced expression of alfa-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
485 Pirskanen M et al. An association between a subset of Finnish late-onset Alzheimer´s disease and alpha2-macroglobulin.
486 Pirttilä T, ed. The Second Kuopio Alzheimer Symposium. Kuopio Music Centre, Kuopio, Finland March 13-15, 2001. Program and abstracts.
487 Pirttilä T. Kolinerginen lääkehoito Alzheimerin taudissa - osa hyvää hoitoa.
488 Pirttilä T. Kliininen tutkimus.
489 Pirttilä T. Laboratoriotutkimukset.
490 Pirttilä T. Biologiset merkkiaineet.
491 Pirttilä T. Targeted drug treatment for Alzheimer´s disease.
492 Pirttilä T, Erkinjuntti T. Alzheimerin taudin kliininen kuva ja diagnoosi.
493 Pirttilä T, Oksi J. Tarvitaanko selkäydinnestetutkimuksia 2000-luvulla?
494 Pirttilä T-RM et al. Ex vivo MR microimaging of neuronal damage after kainate-induced status epilepticus in rat: correlation with quantitative histology.
495 Polvikoski T et al. Prevalence of Alzheimer's disease in very elderly people. A prospective neutopathological study.
496 Poutanen T et al. Transthoracic three-dimensional echocardiography is as good as magnetic resonance imaging in measuring dynamic changes in left ventricular volyme during the heart cycle in children.
497 Pukander J et al. Endoscopic laser surgery for laryngeal cancer.
498 Pukkila MJ et al. Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.
499 Pulkkanen K. Gene Therapy for Human Renal Cell Carcinoma in an Orthotopic Nude Mouse Model.
500 Pulkkanen KJ et al. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
501 Puntila E et al. Leisure-time physical activity and rate of bone loss among peri- and postmenopausal women: a longitudinal study.
502 Purhonen M et al. Effects of maternity on auditory event-related potentials to human sound.
503 Purhonen M et al. Dynamic behavior of the auditory N100 elicited by a baby`s cry.
504 Purokivi MK et al. Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes.
505 Puurunen K. The Effects of Pharmacotherapy and Training on Functional Recovery after Global and Focal Cerebral Ischemia in Rats.
506 Puurunen K et al. An alfa2-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats.
507 Puurunen K et al. Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
508 Puurunen K et al. Enriched-environment housing increases neuronal Fos-staining in the dentate gyrus after a water maze spatial learning task.
509 Puustjärvi TJ, Teräsvirta ME. Retinal fixation of traumatic retinal detachment with metallic tacks.
510 Pyörälä K, Klaukka T. Sepelvaltimotauti-, diabetes- ja verenpainepotilaiden lipidilääkkeiden käyttö Suomessa vuosina 1996-99.
511 Pyörälä K et al. Toteutuvatko sepelvaltimotaudin sekundaaripreventiota koskevat suositukset?
512 Pääkkönen AK, Morgan MJ. Linear mechanisms can produce motion sharpening.
513 Pölkki T et al. Nonpharmacological methods in relieving children's postoperative pain: a survey on hospital nurses in Finland.
514 Raamat R et al. Continuous mean arterial pressure measurement in the fingers: the influence of local arm cooling.
515 Rahiala E, Tikanoja T. Suspicion of aortic coarctation in an outpatient clinic: How should blood pressure measurements be performed?
516 Rahkonen T et al. Delirium in the non-demented oldest old in the general population: risk factors and prognosis.
517 Rahkonen T et al. Systematic intervention for supporting community care of elderly people after a delirium episode.
518 Raitanen M-P et al. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
519 Raitanen MP et al. Human complement factor H related protein test for monitoring bladder cancer.
520 Randell KM et al. Hormone replacement therapy and risk of falling in early postmenopausal women-a population-based stydy.
521 Rankinen T et al. The human gene map for performance and health-related fitness phenotypes.
522 Raunio P et al. Preliminary description of antigenic components characteristic of Stachybotrys chartarum.
523 Rauramaa R, Lakka TA. Liikuntaa sepelvaltimotaudin ehkäisyyn ja hoitoon.
524 Rauramaa R et al. Dose-response and coagulation and hemostatic factors.
525 Rautiainen J et al. Two new variants of the lipocalin allergen Bos d 2.
526 Rautio S. Leikkaussalin valaistus - tilan vai tehtävien ehdoilla?
527 Reijonen T et al. Pikkulasten astma.
528 Repo-Tiihonen E et al. Mortality of antisocial male criminals.
529 Riikonen R. Neurotrophic factors in the pathogenesis of Rett syndrome.
530 Riikonen R. Epidemiological data of West syndrome in Finland.
531 Riikonen R. ACTH therapy of West syndrome: Finnish views.
532 Riikonen R. The PEHO syndrome.
533 Riikonen R. Long-term outcome of patients with West syndrome.
534 Rissanen P et al. Weight change and blood coagulability and fibrinolysis in healthy obese women.
535 Rissanen S et al. Yli 75-vuotiaiden vanhusten yksityisten ja julkisten lääkäri- ja kotipalvelujen käyttö.
536 Rissanen TH et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study.
537 Rissanen TT et al. Gene therapy for therapeutic angiogenesis in critically inschaemic lower limb - on the way to the clinic.
538 Ristikankare M et al. The effects of gender and age on the colonoscopic examination.
539 Riukka L et al. Lääkäreiden ja sairaanhoitajien odotukset sairaala-apteekkien lääkeinformaatiopalvelulta.
540 Romppanen EL. Oligonucleotide ligation assay: application to molecular diagnosis os inherited disorders.
541 Ronkainen A et al. Evidence for excess long-term mortality after treated subarachnoid hemorrhage.
542 Ronkainen S, Syrjänen M. Ammatillisen osaamisen kehittäminen.
543 Roponen M et al. Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders.
544 Roponen M et al. Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders.
545 Ropponen KM et al. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
546 Roschier M et al. Insulin-like growth factor binding protein 5 and type- 1 insulin-like growth factor receptor are differentially regulated during apoptosis in cerebellar granule cells.
547 Rouvinen J et al. Search for the determinants of allergenicity in proteins of the lipocalin family.
548 Ruoppi P et al. Paranasal sinus mucormycosis: a report of two cases.
549 Ruoppi P et al. In vitro and in vivo responses to the recombinant bovine dander allergen Bos d 2 and its fragments.
550 Ruponen M et al. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes.
551 Rutanen J et al. Clinical applications of vascular gene therapy.
552 Ruutiainen J, Sivenius J. Etenevät neurologiset sairaudet.
553 Ryynänen O-P et al. General practitioners' willingness to request plain lumbar spine radiographic examinations.
554 Räihä I et al. Poor performance in the Mini-Mental State Examination due to causes other than dementia.
555 Räsänen JV et al. Health-related quality of life before and after gastrointestinal surgery.
556 Saano S, Naaranlahti T. Serotoniinioireyhtymä.
557 Saarelainen T et al. trkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis.
558 Saarenmaa I et al. The visibility of cancer on previous mammograms in retrospective review.
559 Saarenmaa I et al. Validity of radiological examinations of patients with breast cancer different age groups in a population based study.
560 Saarenmaa I et al. The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultrasonography.
561 Saari KM et al. Silmän tutkiminen.
562 Saarikoski S. Raskauden keston häiriöt.
563 Saarinen J. Mast Cell Mediators in Immediate Allergic Wheal Reaction.
564 Saarinen JV et al. Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects on leukotriene C4 and prostaglandin D2.
565 Saarinen JV et al. Interleukin-4-posituve mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
566 Saarinen JV et al. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
567 Saarinen P. Itsetuhoisuus skitsofreniassa.
568 Saarinen P et al. Läheisen itsemurhaan sopeutuminen.
569 Sahlman J et al. Premature vertebral endplate ossification and mild disc degeneration in mice after inactivation of one allele belonging to the Col2a1 gene for Type II collagen.
570 Salmenkivi K et al. Inhibin/activin beta-B-subunit expression in pheochromocytomas favors benign diagnosis.
571 Salmenperä T. Damage in the Hippocampus, Amygdala, Entorhinal and Perirhinal cortex of Adults With Partial Epilepsy.
572 Salmenperä T et al. Hippocampal and amygdaloid damage in partial epilepsy A cross-sectional MRI study of 241 patients.
573 Salmi L, Niinimäki J. Selviytyykö lääkäri verkossa?
574 Salmén T et al. Estrogeenireseptori alfa-geenin polymorfia vaikuttaa hormonikorvaushoidon luustolle antamaan suojaan.
575 Salomaa V et al. Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events: the FINMONICA MI Register Studt.
576 Salonen A et al. I.V. ketoprofen for analgesia after tonsillectomy: comparison of pre- and post-operative administration.
577 Sarkkinen R et al. Keski-Suomen keskussairaalassa vuosina 1983-1990 ja 1991-1998 hoidetut myeloomapotilaat.
578 Savolainen S et al. Auditory event-related potentials differentiate patients with normal pressure hydocephalus and patients with concomitant Alzheimer´s disease verified by brain biopsy.
579 Savolainen S, Vapalahti M. Hydrokefaalinen dementia.
580 Schmidt D et al. Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view.
581 Schmidt-Trucksäss A et al. Computerized analysing system using the active contour in ultrasound measurement of carotid artery intima-media thickness.
582 Schreiner PJ et al. Gender differences in recurrent coronary events: The FINMONICA MI register.
583 Second SYMPHONY Investigators. Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
584 Sentman M-L et al. Extracellular superoxide dismutase deficiency and atherosclerosis in mice.
585 Serlo W et al. Use of self-reinforced polyactide osteosynthesis devices in craniofacial surgery: A long-term follow-up study.
586 Setälä L et al. Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
587 Siloaho M et al. A pilot experiment of joint assessments by accreditation bobies in clinical laboratories.
588 Siloaho M et al. Key elements of the implementation of a quality system in three Finnish clinical laboratories.
589 Silver HM et al. Comparison of vagal baroreflex function in nonpregnant women and in women with normal pregnancy, preeclampsia, or gestational hypertension.
590 Simula S. Cardiac Adrenergic Innervation in Coronary Artery Disease - Studies with I123-metaiodobenzylguanidine.
591 Sinkkonen ST et al. Characterization of gamma-aminobutyrate type A receptors with atypical coupling between agonist and convulsant binding sites in discrete brain regions.
592 Sivenius J. Ikääntyneen aivohalvauspotilaan hoidon ja kuntoutuksen periaatteita.
593 Sivenius J. Aivohalvauspotilaan kuntoutuksen vaikuttavuus ja käytännön periaatteet.
594 Sivenius J et al. Selegiline treatment facilitates recovery after stroke.
595 Sivenius J, Tarkka IM. Aivovauriot.
596 Sivenius K et al. Effect of a three-amino acid deletion in the alfa2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects.
597 Slotte V et al. Information technology in medical education: a nationwide project on the opportunities of the new technology.
598 Soimakallio S. Katsaus KYS:n sairaanhoitopiirien tilanteeseen ja kehitysnäkymiin.
599 Soimakallio S, Liukko M. Säteilyn lääketieteellisen käytön kliininen auditointi.
600 Soimakallio S, Pamilo M. Kuvantamistoiminnan nykytila Suomessa.
601 Soimakallio S, Pyhtinen J. Röntgenlähete juridisena asiakirjana.
602 Soininen H. Muistihäiriöiden ja dementian ennaltaehkäisy.
603 Soininen H, Hänninen T. Muistihäiriöiden oirediagnostiikka.
604 Soininen H, Partanen J. Kliinis-neurofysiologiset tutkimukset.
605 Sorri I. Effects of Antiepileptic Drugs on Visual Function, with Special Reference to Vigabatrin.
606 Sudah M et al. MR urography in evalution of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography.
607 Sulkava R. Dementiapotilaan käytösoireet.
608 Sulkava R. Neurogeriatria.
609 Suomalainen S et al. Pulmonary infection caused by an unusual, slowly growing nontuberculous Mycobacterium.
610 Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä. Dementiapotilaiden käytösoireet.
611 Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä:. Dementiapotilaiden käytösoireiden lääkkeetön hoito.
612 Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä:. Dementiaan liittyvien käytösoireiden lääkehoito.
613 Suominen MM et al. Effects of intra-articular injections of bufexamac suspension in healthy horses.
614 Suppola S et al. Concurrent overexpression of ornithine decarboxylase and spermidine/spermine N1-acetyltransferase further accelerates the catabolism of hepatic polyamines in transgenic mice.
615 Sutula TP, Pitkänen A. More evidence for seizure-induced neuron loss: is hippocampal sclerosis both cause and effect of epilepsy?
616 Säilä HM et al. Juvenile idiopathic arthritis in multicase families.
617 Tacke U. Tietoa huumeista ja huumeiden käyttäjistä.
618 Tacke U, Tuomisto J. Riippuvuus ja väärinkäyttö.
619 Tacke U et al. The effect of tobacco smoking on subjective symptoms of inadequacy ("not holding") of methadone dose among opiate addicts in methadone maintenance treatment.
620 Taipale P, Heinonen S. Trisomiaseulonnan nykytila.
621 Taipale P, Hiilesmaa V. Predicting delivery date by ultrasound and last menstrual period in early gestation.
622 Takala J et al. Nutrition support in trauma and sepsis.
623 Tammi R et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism.
624 Tanila H. Noradrenergic regulation of hippocampal place cells.
625 Tanner SM et al. BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia.
626 Tanskanen A et al. Fish consumption, depression, and suicidality in a general population.
627 Tanskanen A et al. Fish consumption and depressive symptoms in the general population in Finland.
628 Tanskanen A et al. Nightmares as predictors of suicide.
629 Tanskanen A, Viinamäki H. Drs. Tanskanen and Viinamäki reply.
630 Tapiola T. Biological Markers for Alzheimer´s Disease.
631 Tapiola T et al. CSF tau and Abeta42 levels in patients with Down´s syndrome.
632 Tarkiainen R et al. Lapsiperheiden varhaisen tuen työmenetelmiä. Pienryhmätoiminta lapsiperheiden tukena: videoidut palautekeskustelut pienryhmätoiminnasta.
633 Tarkka IM. Cerebral sources of electrial potentials related to human vocalization and mouth movement.
634 Tarkka IM et al. Altered frontal lobe function suggested by source analysis of event-related potentials in impulsive violent alcoholics.
635 Tarvainen MP et al. Analysis of galvanic skin responses with principal components and clustering techniques.
636 Taskinen T. Moisture and Mould Problems in School Buildings.
637 Taskinen T et al. Mold-specific IgE antibodies in relation to exposure and skin test data in schoolchildren.
638 Tenhunen JJ et al. Gut luminal lactate release during gradual intestinal ischemia.
639 Tenhunen JJ et al. Gastric mucosal systemic partial pressure of carbon dioxide (PCO2) gradient in experimental endotoxin shock in swine - comparison of two methods.
640 Teräsvirta M, Saari KM. Mykiö ja sen sairaudet.
641 The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigato. Effects of clopidogrel in addition to aspirin in patietns with acute coronary syndromes without st-segment elevation.
642 The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality.
643 The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy of combination reduced fibrinolytic therapy and platelet glucoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
644 Tiainen S. Informaatioteknologiaa terveydenhuollon ammattilaisille.
645 Tiihonen J. Recidivistic violent behavior and axis I and axis II disorders.
646 Tiihonen J. Oikeuspsykiatria.
647 Tiihonen J et al. Free L-tryptophan plasma levels in antisocial violent offenders.
648 Tikka T et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
649 Tikka T et al. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation.
650 Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia.
651 Timonen M et al. Association between atopic disorders and depression: findings from the Northern Finland 1966 birth cohort study.
652 Tommiska V et al. A national short-term follow-up study of extremely low birth weight infants born in Finland in 1996-1997.
653 Torkko P et al. Characterization of Mycobacterium bohemicum isolated from human, veterinary and environmental sources.
654 Tuhkanen K et al. Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates.
655 Tukiainen H. Rintaan koskee - syy keuhkoissa?
656 Tuomainen R. Terveyden palvontaan - medikalisaation luomat uhkavisiot.
657 Tuomainen R et al. Selvitysmieshanke sairaalassa - prosessi ja opetuksia.
658 Tuomainen R, Tuomainen M. Mikä maksaa - sairaanhoitopiirien vertailua benchmarking-tiedoin.
659 Tuomilehto J et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study.
660 Tuomilehto J et al. Authors's reply (Sodium excretion and cardiovascular mortality).
661 Tuomilehto J et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance .
662 Tuomisto L et al. Changes in circadian rhythmicity and melatonin balance in rats with portacaval anastomosis (PCA) - relation with histamine.
663 Tupala E et al. Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics.
664 Tupala E et al. Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography.
665 Tupola S et al. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
666 Töyry E. Hoidon ihmisläheisyys erikoissairaanhoidossa. Mittarin kehittäminen ja käyttö.
667 Töyry E, Vehviläinen-Julkunen K. Developing an instrument for the measurement of humane caring.
668 Töyräs J. Mechano-Acoustic Characterization of Articular Cartilage and Trabecular Bone.
669 Töyräs J et al. Estimation of the Young's modulus of articular cartilage using an arthroscopic indentation instrument and ultrasonic measurement of tissue thickness.
670 Udd M et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding.
671 Uusimaa P et al. Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
672 Uusitalo ALT. Making a difficult diagnosis and implementing targeted treatment .
673 Uusitupa M. Liikunta ja ruokavalio ovat metabolisen oireyhtymän täsmähoitoa.
674 Uusitupa M. Aikuistyypin diabeteksen ehkäisy - haaste terveydenhuollollemme.
675 Uusitupa M, Tuomainen R. Yhteistyö sairaanhoitopiirien välillä Suomessa.
676 Vaag A et al. Metabolic impact of a family history of type 2 diabetes. Results from a European multicentre study (EGIR).
677 Valkamo M et al. Alexithymia in patients with coronary heart disease.
678 Valkamo M et al. Depression and associated factors in coronary heart disease.
679 Valkamo M et al. Psychiatric morbidity and the presence and absence of angiographic coronary disease in patients with chest pain.
680 Valkonen-Korhonen M et al. Loss of time-organized sympathetic skin responses in acute psychosis.
681 Valle TT et al. Tyypin 2 diabetes on ehkäistävissä elämäntapamuutoksilla.
682 Valtonen HJ et al. Tegmental defects and cerebrospinal fluid otorrhea.
683 Valve R. Studies on Genetic Regulation of Basal Metabolic Rate in Obese Subjects.
684 Vanamo K, Kiekara O. Pylephlebitis after appendicitis in a child.
685 Vanamo T et al. Intra-familial child homicide in Finland 1970-1994: incidence, causes of death and demographic characteristics.
686 Vandenberghe S et al. Iterative reconstruction algorithms in nuclear medicine.
687 Vanhala R et al. Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.
688 Vanhanen M et al. APOE-epsilon4 is associated with weight loss in women with AD . A population-based study.
689 Vanhatalo S et al. Reversed visual field constrictions in children after vigabatrin withdrawal-true retinal recovery or improved test performance only?
690 Vanhatalo S, Riikonen R. Nitric oxide metabolites, nitrates and nitrites in the cerebrospinal fluid in children with west syndrome.
691 Vapaavuori J. Dialoginen muutos ryhmäkeskusteluissa: työyhteisön jumi konsultaation kohteena.
692 Vapalahti M. Comments (to Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrgage: a problem of neurointensive care).
693 Vapalahti M. Comment to (Surgical treatment of chronic subdural hematoma based on intrahematomal membrane structure on MRI).
694 Vapalahti M. Comment to (Radiologically confirmed de novo glioblastoma multiforme and hippocampal sclerosis associated with the first onset of nonconvulsive simple partial status.
695 Vapalahti M. Comment to (Metastatic brain tumours from oesophageal carcinoma: Neuro-imaging and clinicopathological characteristics in Japanese patients).
696 Vapalahti M. Comment to (A scanning technique to measure regional cerebral blood flow and oxyhemoglobin level).
697 Vapalahti M. Comment to (The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study.
698 Vapalahti M. Comment to (Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations).
699 Vartiainen N et al. Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition.
700 Vauhkonen I. Early Defects in Glucose Metabolism in Relatives of Patients with Different Phenotypes of Diabetes Mellitus.
701 Venesmaa PK et al. Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry - a 3-year follow-up study.
702 Venesmaa PK et al. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: A prospective randomized study.
703 Vesala H-H. Laskentamalli ja sovellusesimerkkejä.
704 Vesala H-H. Filmiarkistosta digitaaliarkistoon: Itä-Suomi.
705 Vesala H-H. PACS:n tärkein tavoite on parantaa potilaan hoitoa.
706 Vesala H-H. Filmiarkistointiin käytetty työaika ja palkkakustannukset.
707 Vesala H-H et al. Perinteisestä filmikuvantamisesta digitaalikuvantamiseen.
708 Vesala H-H et al. Mitä vaikuttaa siirtyminen röntgenfilmiarkistoinnista digitaaliarkistointiin.
709 Vessby B et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women:The KANWU study.
710 Videman T et al. The relative roles of intragenic polymorphisms of the vitamin D receptor gene in lumbar spine degeneration and bone density.
711 Viinamäki H et al. Masennuspotilaat psykiatrisessa osastohoidossa.
712 Viinamäki H et al. Pitkäaikaiseen masentuneisuuteen liittyvät tekijät yleisväestössä.
713 Viitanen L. Studies on the Genetic Basis of Premature Coronary Heart Disease Using Candidate Gene Approach and Genome-Wide Scanning.
714 Viitanen L et al. Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.
715 Viitanen L et al. Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease.
716 Viramo P, Sulkava R. Muistihäiriöiden ja dementian epidemiologia.
717 Virtanen T. Lipocalin allergens.
718 Virtaniemi JA et al. Surgical management of irradiation failures in T1-T2 squamous cell carcinoma of the glottic larynx.
719 Virtaniemi JA et al. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae.
720 Vornanen M, Jantunen E. T-solulymfoomat: WHO:n luokitus, kliiniset piirteet ja hoitoperiaatteet.
721 Voutilainen-Kaunisto R. Aikuistyypin diabetekseen liittyvät silmänpohjamuutokset ja riskitekijät.
722 Voutilainen-Kaunisto R. Ocular Manifestations in Type 2 Diabetes. Controlled Ten-Year Follow-Up Study.
723 Voutilainen-Kaunisto R et al. Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: A 10-year follow-up study.
724 Voutilainen-Kaunisto RM et al. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis.
725 Vuorio AF et al. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences.
726 Vuoristo M-S et al. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
727 Väisänen M et al. Leikkauksen jälkeinen kipu vaihtelee lapsen mukaan.
728 Välimäki MJ et al. Lasten riisitaudista aikuisten osteomalasiaan.
729 Välimäki S et al. Relation of collagen type I alpha 1 (COLIA1) and vitamin D receptor genotypes to bone mass, turnover, and fractures in early postmenopausal women and to hip fractures in elderly people.
730 Väätäinen U. Poikkitankokiinnitys eturistisiteen kirurgiassa. Alustavat tulokset.
731 Väätäinen U. Nivelkierukan siirre. Indikaatiot ja tulokset.
732 Wahlfors J et al. Green fluorescent protein (GFP) fusion constructs in gene therapy research.
733 Waldemar G et al. Benefits of donepezil on cognition, function and neuropsychiatric symptoms in patients with mild and moderate Alzheimr´s disease over one year.
734 Wang H et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes.
735 Wangel M et al. WWW--an effective way of teaching radiology.
736 Wedel H et al. Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial.
737 Wilhelmsen L et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S): Impact of predicted risk on the benefit of cholesterol-lowering treatment.
738 Winblad B et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
739 Wood D et al. Rapid assessment of chest pain: The rationale is clear, but evidence is needed.
740 Ylinen A et al. Kognitiivisten toimintojen neurobiologinen tausta.
741 Ylinen A, Kanto-Ronkanen A. Seizure-Warning systems and protective adjustments.
742 Ylinen J et al. Kuntoutustarve lannerangan välilevytyräleikkauksen jälkeen.
743 Ylinen J et al. Kirjoittajien vastine edelliseen (Kuntoutustarve lannerangan välilevytyräleikkauksen jälkeen).
744 Ylitalo K et al. Reversible ischemic inhibition of F1F0-ATPase in rat and human myocardium.
745 Ylitalo K et al. Evidence suggesting coronary vasodilation as the principal mechanism in the warm-up phenomenon.
746 Ylitalo K, Peuhkurinen K. Tuumorinekroositekijä alfa ja sydän - voidaanko sydänsairauksia hoitaa sytokiineja neutraloimalla?
747 Ylitalo K, Peuhkurinen K. Clinical relevance of ischemic preconditioning.
748 Ylä-Herttuala S. Geeniterapia.
749 Ylä-Herttuala S. Gene therapy for coronary heart disease.
750 Zhou J et al. Inverse T2 contrast at 1.5 tesla between gray matter and white matter in the occipital lobe of normal adult human brain.
751 Äikiä M et al. Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy.
752 Ågren JJ et al. Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene 1,2.
753 Åmark P et al. Risk prevention in daily life.
754 Örmälä T et al. T cells of the colonic mucosa in patients with infantile colitis.

Kuopion yliopistollinen sairaala Kuopio University Hospital
Julkaisutietokanta 15.1.2003 Publications Data Base 15.1.2003